Circulating tumour DNA is a promising biomarker for risk stratification of central chondrosarcoma wi...
Circulating tumour DNA is a promising biomarker for risk stratification of central chondrosarcoma with IDH1/2 and GNAS mutations
About this item
Full title
Author / Creator
Lyskjær, Iben , Davies, Christopher , Strobl, Anna‐Christina , Hindley, Joanna , James, Steven , Lalam, Radhesh K. , Cross, William , Hide, Geoff , Rankin, Kenneth S. , Jeys, Lee , Tirabosco, Roberto , Stevenson, Jonathan , O’Donnell, Paul , Cool, Paul , Flanagan, Adrienne M. and Genomics England Research Consortium
Publisher
United States: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Chondrosarcoma (CS) is a rare tumour type and the most common primary malignant bone cancer in adults. The prognosis, currently based on tumour grade, imaging and anatomical location, is not reliable, and more objective biomarkers are required. We aimed to determine whether the level of circulating tumour DNA (ctDNA) in the blood of CS patients cou...
Alternative Titles
Full title
Circulating tumour DNA is a promising biomarker for risk stratification of central chondrosarcoma with IDH1/2 and GNAS mutations
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_06050dfe09da4f93b0994c5d65b4ce29
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_06050dfe09da4f93b0994c5d65b4ce29
Other Identifiers
ISSN
1574-7891
E-ISSN
1878-0261
DOI
10.1002/1878-0261.13102
